|
ARMC8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.33010000014089E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.589000E-01 |
| Stage1-vs-Stage3 |
4.539100E-03 |
| Stage1-vs-Stage4 |
5.981300E-04 |
| Stage2-vs-Stage3 |
3.838500E-03 |
| Stage2-vs-Stage4 |
1.256590E-03 |
| Stage3-vs-Stage4 |
4.608400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.11810000003043E-06 |
| Normal-vs-Asian |
3.33899574656016E-12 |
| Caucasian-vs-AfricanAmerican |
2.100600E-01 |
| Caucasian-vs-Asian |
8.859600E-01 |
| AfricanAmerican-vs-Asian |
2.701000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.366400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65334412827178E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
5.55759999999461E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.304560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.274780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.943800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.613600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.553200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.832400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.953670E-04 |
| Classical-VS-Follicular |
1.143170E-01 |
| Classical-VS-Other |
6.217200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.17249999999925E-05 |
| Tall-VS-Other |
1.932770E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
3.848600E-01 |
| Follicular-VS-Normal |
5.15250000443501E-08 |
| Other-VS-Normal |
2.423000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
1.04360964314765E-14 |
| N0-vs-N1 |
3.346100E-02 |
|
|
